|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Embryo |
a Division of Research, Department of Obstetrics, Gynecology and Women's Health, University of Louisville Health Sciences Center, Louisville, Kentucky 40292
| ABSTRACT |
|---|
|
|
|---|
10 two-cell bovine embryos with bovine oviductal epithelial cells increased the development of the embryos into blastocysts. Treatment of these cocultures with hCG, used as a surrogate for LH because of its stability and purity, further increased embryo development. The hCG effect is dose dependent and hormone specific and requires the dimer conformation and the presence of LH receptors in oviductal epithelial cells. The inhibition of OGP synthesis and prevention of protein kinase A activation blocked the hCG effect in cocultures. Reverse transcription polymerase chain reaction and indirect immunofluorescence with laser scanning confocal microscopy demonstrated the presence of LH receptors in bovine oocytes, embryos, and blastocysts. However, embryo LH receptors may not have played any role in the beneficial hCG effects in cocultures. These findings suggest that elevated periovulatory LH levels may promote preimplantation embryo development in oviducts. These results have important implications for assisted reproductive technologies in which cocultures are used to improve pregnancy rates.
early development, embryo, human chrionic gonadotropin, luteinizing hormone, oviduct
| INTRODUCTION |
|---|
|
|
|---|
| MATERIALS AND METHODS |
|---|
|
|
|---|
The following were obtained from various colleagues: monoclonal antibody to bovine OGP (1H10) from Dr. Yutaka Sendai (Research Institute for the Functional Peptides, Yamagata, Japan); glyceraldehyde-3-phosphate dehydrogenase (GAPDH) cDNA from Dr. Russell Prough (University of Louisville Health Sciences Center); polyclonal antibody raised against a synthetic N-terminus 15- to 38-amino acid sequence of LH receptors from Dr. Patrick Roche (Mayo Clinic, Rochester, MN); highly purified hCG (CR-127; 14 900 IU/mg), human LH (AFP-0264B; 4015 IU/mg), human FSH (AFP-87929B, 1683 IU/mg), human thyroid-stimulating hormone (TSH, AFP-4314C; 15 IU/mg),
subunit (AFP8492A) and ß subunit (AFP8494A) of hCG from NIDDK National Hormone & Pituitary Program and Dr. A.F. Parlow (Torrance, CA). The rest of the materials were purchased from various sources. Trizol, horseradish peroxidase-labeled anti-rabbit IgG, antibiotic-antimycotic solution (10 000 U/ml penicillin, 10mg/ml streptomycin and 25 µg/ml fungizone), Percoll, Ca2+, Mg2+ and phenol-free 10x Hanks balanced salt solution (HBSS), and medium 199 with glutamate and insulin were from Gibco BRL (Grand Island, NY). Fetal bovine serum (FBS) was from Atlanta Biologicals (Norcross, GA). Streptavidin-horseradish peroxidase conjugate, monoclonal antibodies to epithelial cell membrane antigen (EMA) and vimentin were from Dako (Carpenteria, CA). MasterAmp reverse transcription polymerase chain reaction (RT-PCR) kits were from Eipicenter Technologies Corp. (Madison, WI). The dNTPs, DNase-I and random prime labeling kits were from Promega Corp. (Madison, WI). Collagenase (type IA-S; 320 U/mg solid) and anti-rabbit IgG fluorescein isothiocyanate (FITC) conjugate were from Sigma (St. Louis, MO). The 4',6'-diamidino-2-phenylindole (DAPI) was from Molecular Probes (Eugene, OR), the isoquinoline-sulfonamide (H-89) and bisindolylmaleimide (Bis) were from Calbiochem (San Diego, CA), and the two-cell bovine embryos were from BOMED (Bovine Oocyte Maturation and Embryo Development, Madison, WI). The embryos were shipped overnight in a special container with an insulated thermoregulated package with battery pack and charging unit to maintain the temperature at 39°C (Minitube of America, Verona, WI). Upon receipt, the embryos were washed twice in medium 199 containing 10% FBS pre-equilibrated for 2 h at 38.6°C in 5% CO2 and 95% air. Only healthy looking compact two-cell embryos were used in the experiments.
Collection of Bovine Ovaries and Oviducts
Late follicular phase ovaries and oviductal ampullary segments were collected from a local slaughter house, immediately placed either in ice cold PBS (ovaries) or in medium 199, pH 7.4, containing 10% FBS, 10 µg/ml insulin, 2% antibotic-antimycotic mixture (oviducts), and brought to the laboratory. The oocytes were aspirated from 2- to 5-mm follicles and washed twice in 10 mM Hepes containing 125 mM NaCl, 3 mM KCl, 2 mM NaHCO3, 0.4 mM Na2HPO4, 10 mM sodium lactate, 2 mM Ca2+, and 0.5 mM Mg2+. The oocytes were then gently vortexed for 90 sec and pipetted several times through a glass Pasteur pipette to dislodge and remove cumulus cells. Then cumulus-free oocytes were then washed in medium 199 and processed for indirect immunofluorescence and laser scanning confocal microscopy. The oviducts were processed for cell dispersion.
Cell Dispersion
The ampullary segments were flushed with 10 ml of Ca2+, Mg2+, and phenol red-free HBSS and then cut open longitudinally to expose the epithelial cell layer [13, 16]. The tissues were then digested for 45 min at 37°C in a shaking water bath in capped sterile tubes containing 5 ml of 1% collagenase in medium 199. The digested tissues were first strained through a 250-µm pore size nylon mesh while gently scraping the mucosal folds. The filtrate was then passed through a 30-µm pore size nylon mesh. The epithelial cells retained on the mesh were backwashed with 20 ml of 1x HBSS containing a 2% antibiotic-antimycotic mixture. The backwash solutions containing enriched epithelial cells were centrifuged for 30 min at 1500 x g in 5060% Percoll solution to pellet contaminating red blood cells and cellular debris. The epithelial cells present in the upper Percoll layer were removed and placed in a 10% antibiotic-antimycotic mixture. About 95% of the cells were immunostained with an anti-EMA antibody, which binds to epithelial cells, and the rest were immunostained with an anti-vimentin antibody, which binds to fibroblasts. Cell viability, which was determined by trypan blue exclusion, was >95%.
Coculture
Oviductal epithelial cells (0.6 x 106 cells/well) were cultured for 48 h in 24-well culture plates in medium 199 containing 10% FBS in a humidified 5% CO2 atmosphere in a CO2 incubator [34, 35]. The monolayers were washed twice in medium 199 to remove unattached cells. Where oligodeoxynucleotide (ODN) treatments were indicated, these compounds were added with 10 µg/ml lipofectamine to the fresh replacement medium. After 24 h, various hormones and test agents were added. After an additional 24 h, the medium was replaced with fresh medium of the corresponding composition, and groups of 1015 two-cell embryos were randomly transferred in microdrops. The embryos were covered with 2530 µl of mineral oil and cultured for another 5 days, with medium changes every 48 h with corresponding fresh medium. The treatments were maintained until the end of the culture. In some experiments (Fig. 1), two-cell embryos were placed in pre-equilibrated 100-µl culture drops of medium 199 containing 10% FBS with or without hCG and were covered with mineral oil. The development of two-cell embryos into blastocysts was monitored daily with an inverted light microscope. Only those embryos containing >36 cells and a cavity were counted as blastocysts.
|
Design and Synthesis of Phosphorothioate ODNs
Twenty-four-base pair (bp) (LH receptor) and 27-bp (OGP) sequences spanning the translation initiation ATG codons of porcine LH receptor and bovine OGP genes were designed using a designer PCR computer program (Research Genetics, Huntsville, AL). The phosphorothioate ODN sequences were synthesized using a Pharmacia LKB Gene Assembler Special automated DNA synthesizer with a standard phosphoramidate chemical procedure and were desalted on NAP-10 columns. The antisense and sense sequences were as follows: LH receptor antisense, 5'-AGC GCC AGG GAC CGC CGT CTC ATG-3'; LH receptor sense, 5'-CAT GAG ACG GCG GTC CCT GGC GCT-3'; OGP antisense, 5'-CAG ATC CCG AGG CAG GAT TGA GGC AGG-3'; OGP sense, 5'-GTC TAG GGC TCC GTC CTA ACT CCG TCC-3'.
Immunocytochemistry
Cell monolayers were fixed in 3% paraformaldehyde for 30 min and processed for immunostaining for LH receptors or OGP by an avidin-biotin immunoperoxidase method [8]. Dilutions of 1:400 for LH receptor antibody and 1:500 for OGP antibody were used. Nonspecific IgG was used in procedural controls.
Reverse Transcription Polymerase Chain Reaction
Total RNA was isolated by the Trizol method from about 50 oocytes and early embryos. Then RT and 40 cycles of PCR were performed in the same tubes with bovine LH receptor or GAPDH primers using MasterAmp RT-PCR kits. The PCR products were electrophoresed in 2% NuSieve agarose gels and stained with ethidium bromide. A 123-bp DNA ladder was included in an adjacent lane to determine the sizes of the amplified fragments. The expected sizes of these amplified fragments were 458 bp for LH receptors and 374 bp for GAPDH.
The sequences of primers used for the LH receptor and GAPDH amplification were as follows: LH receptor, 5'-GCC TGA CAT CAA GGA GAA GC-3' (forward) and 5'-CAG GGA AAT CAG CGT TGT CC-3' (reverse); GAPDH, 5'-TGG ACT CCA CGA CGT ACT CA-3' (forward) and 5'-CTC TCT GCT CCT CCT CTT CG-3' (reverse).
Indirect Immunofluorescence and Laser Scanning Confocal Microscopy
Oocytes and embryos were fixed for 30 min in 3% paraformaldehyde in PBS and permeabilized by exposure to Tyrode solution, pH 2.5 [36]. They then were incubated overnight at 4°C with a 1:50 dilution of LH receptor antibody followed by 2 h of incubation with FITC-conjugated secondary antibody. Oocytes and embryos were then washed thoroughly in PBS, and nuclei were stained with 300 nM DAPI for 15 min, rinsed several times with PBS, mounted in fluoromount G, and scanned by a Leica 4D TCS laser confocal microscope. Nonspecific IgG and primary antibody omission were used as procedural controls. The binding of FITC-labeled secondary antibody gave green fluorescence, and DAPI stained the nuclei blue.
Statistical Analysis
All the experiments were performed in triplicate and were repeated three times with cells isolated from different oviducts. The data from all the experiments were pooled for the calculation of means and SEMs. An ANOVA with a Duncan multiple range test was used for determining the significance of differences between experimental groups [37].
| RESULTS |
|---|
|
|
|---|
Two-cell embryos have an inherent low capacity to develop into blastocyts. This capacity, under different culture conditions, was investigated first. The development of two-cell embryos in culture medium was modest regardless of embryo number, until there were about five embryos in the culture (Fig. 1). At 10 embryos/culture, however, the development increased (P < 0.05). The addition of highly purified hCG had no effect, regardless of embryo number.
Coculture of two-cell embryos with oviductal epithelial cells had no effect on their development until 10 embryos were used per culture (P < 0.05). The addition of hCG to cocultures increased embryo development when
5 embryos were used per culture (P < 0.05). These data formed the basis for coculturing 1015 embryos with oviductal epithelial cells in the remaining experiments.
Effect of hCG in Cocultures
The addition of 0.51.0 ng/ml hCG had no effect on two-cell embryo development in cocultures (Fig. 2). However, embryo development increased following the addition of 10 ng/ml hCG, but a further increase in hCG concentrations had no effect beyond that achieved with 10 ng/ml (P < 0.05; Fig. 2). Only LH, but not FSH, TSH, or isolated
and ß subunits of hCG, mimicked hCG in increasing embryo development in cocultures (Fig. 3).
|
|
Requirement of LH Receptors for the hCG Effect in Cocultures
Even though LH and hCG, and other protein hormones, work by activating their receptors, the receptor requirement in the context of cocultures was investigated by targeted destruction of LH receptor mRNA by an antisense ODN approach. With this approach, antisense ODN recognizes receptor mRNA and forms a duplex that is hydrolyzed by RNase H, thus blocking gene expression. For these experiments, phosphorothioate LH receptor ODNs, which resist degradation by nucleases [38], were synthesized from an LH receptor sequence beginning at the ATG translation initiation codon. Treatment of oviductal epithelial cells with LH receptor antisense but not sense ODN resulted in a dramatic reduction in LH receptor immunostaining (Fig. 4). Although the addition of LH receptor ODNs alone had no effect, cotreatment with antisense, but not sense, ODN blocked the hCG effect on embryo development in cocultures (Fig. 5).
|
|
Role of OGP in Cocultures
Because LH/hCG receptor activation increases OGP synthesis [16, 28], the hypothesis that OGP mediates the hCG effect in cocultures was tested using an antisense strategy. The ODNs were synthesized from a bovine OGP sequence beginning at the ATG translation initiation codon.
As expected, oviductal epithelial cells showed OGP immunostaining (Fig. 6). This staining decreased to procedural control levels after treatment with the OGP antisense ODN. Treatment with the OGP sense ODN, however, had no effect.
|
The ODNs were then used to determine the mediatory role of OGP in the hCG effect in cocultures. Although the addition of OGP ODNs alone had no effect, cotreatment with antisense, but not sense, ODN blocked the hCG effect on embryo development (Fig. 7).
|
Signaling in hCG Action in Cocultures
Cyclic AMP/protein kinase A (PKA) signaling is involved in increasing OGP synthesis following LH/hCG receptor activation [16, 28]. Because the OGP response is required for the hCG effect, we tested the involvement of cAMP/PKA signaling itself in the hCG effect in cocultures. Although H-89, a PKA inhibitor, alone had no effect, cotreatment blocked the hCG effect in cocultures (Fig. 8). However, Bis, a PKC inhibitor, had no effect either alone or when combined with hCG.
|
LH Receptors in Oocytes, Embryos, and Blastocysts
The presence of LH receptor mRNA and protein was investigated by nonquantitative RT-PCR and indirect immunofluorescence and laser scanning confocal microscopy, respectively. The RT-PCR resulted in amplification of an LH receptor fragment of expected size from bovine oocytes, embryos, and oviducts used for a positive control (Fig. 9).
|
Indirect immunofluorescence and laser scanning microscopy revealed the presence of LH receptor protein in oocytes, 8- and 16-cell embryos, and blastocysts (Fig. 10). The immunofluorescence was absent in zona pellucida but was visibly concentrated on the oocyte cell surface and diffuse inside the cell (Fig. 10). The immunofluorescence increased and became patchy in 8-cell embryos, was uniform and diffuse in 16-cell embryos, and became patchy, diffuse, and granular in blastocysts (Fig. 10).
|
| DISCUSSION |
|---|
|
|
|---|
10 embryos. This crosstalk may involve embryo-derived products that act on oviductal epithelial cells to stimulate their synthesis and release of embryotropic factors. The factors from both embryos and oviductal epithelial cells may decrease apoptosis and/or increase cell proliferation, both of which can result in an increased development of embryos [39, 40].
Although addition of hCG had no effect on embryos cultured in medium, it increased embryonic development in cocultures with
5 embryos. The dependence of hCG effect on embryo number in the presence of oviductal epithelial cells suggests a collaboration between hCG and embryotropic factors to further enhance embryo development. The hCG effect was dose dependent. The lack of further increase in embryo development with 100 and 1000 ng/ml hCG suggests that higher hCG concentrations may induce a release of another set of factors that counter the effects of those released by low hCG concentration.
LH, which binds to the same receptors as hCG [41], mimicked hCG. The isolated
and ß subunits of hCG, which do not bind to LH receptors [41], had no effect, suggesting that the dimer hCG conformation is required. FSH and TSH had no effect even though oviducts contain FSH receptors [42]. This lack of effect suggests that FSH plays a role different from that of LH in oviductal functions.
Even though LH and hCG, and other hormones, function by activating their receptors, the receptor requirement in the context of cocultures was investigated by using LH receptor phosphorothioate ODNs. The antisense ODN was designed to inhibit LH receptor synthesis, whereas the sense ODN served as a control. In agreement with previous studies [8, 13, 16, 19, 24, 25], we found that oviductal epithelial cells contain LH receptors. Receptor immunostaining dramatically decreased following treatment with LH receptor antisense, but not sense, ODN. Human CG failed to increase embryo development in oviductal epithelial cells in which LH receptor synthesis was inhibited. This finding suggests that receptors are required for hCG to exert its effects in cocultures.
In view of the finding that LH treatment increases OGP synthesis [16, 28], which probably increases early embryonic growth and development [2933], we tested the OGP requirement in cocultures treated with hCG by using an antisense approach. The phosphorothioate ODNs were synthesized from a bovine OGP sequence. The antisense, but not sense, OGP ODN treatment resulted in a dramatic decrease in OGP immunostaining, indicating a complete inhibition of its synthesis. Human CG failed to increase embryo development in oviductal epithelial cells in which OGP synthesis was inhibited, indicating that OGP mediated the hCG effect in cocultures. The OGP mediation does not necessarily exclude the potential contribution of other factors because they may work only when OGP is present. Thus, in its absence, these factors will not be effective in promoting embryo development.
The cAMP/PKA signaling pathway mediates LH and hCG action to increase OGP levels [16, 28]. Because OGP mediates hCG action, prevention of PKA activation should also block the hCG effect in cocultures, as does inhibition of OGP synthesis. As expected, H-89, which is a selective inhibitor of PKA activation, blocked the hCG effect. The H-89 effect is specific; Bis, which inhibits PKC, was ineffective.
Although there is some evidence that mammalian oocytes and preimplantation embryos contain LH receptors [43, 44], to our knowledge this is the first study demonstrating the presence of these receptors in bovine oocytes, embryos, and blastocysts. We do not know what roles these receptors might play in embryo development, but they probably played no role in the beneficial effect of hCG in cocultures. This hypothesis is based on the finding that hCG addition to embryos cultured in medium alone had no effect.
Our data support numerous studies demonstrating the slow development of embryos when cultured in medium alone [4548], the stimulatory effect of oviductal epithelial cells in cocultures [34, 35, 4955], and the interembryonic cooperation in promoting their own growth and development and in determining the responsiveness to external regulatory factors [47, 56]. The important new finding that emerged from our study was that LH and hCG treatment of cocultures can further increase preimplantation embryo development.
The present findings have important physiological and clinical implications. The physiological implication is that elevated periovulatory serum LH levels may promote preimplantation embryo development in the oviduct. The clinical implication is that hCG treatment of cocultures with reproductive tract epithelial cells, which contain LH/hCG receptors, may further increase pregnancy rates achieved using assisted reproductive technologies [53, 5759].
This is the first study to demonstrate that not only bovine oviductal epithelial cells but also bovine oocytes, embryos, and blastocysts contain LH receptors. Activation of the oviductal epithelial cell receptors in cocultures resulted in increased development of embryos into blastocysts. This effect was dose dependent and hormone specific, required the presence of its receptors, used the cAMP/PKA signaling pathway, and was mediated by OGP.
| FOOTNOTES |
|---|
2 Correspondence. FAX: 502 852 0881; cvrao001{at}gwise.louisville.edu ![]()
Received: 26 September 2002.
First decision: 22 October 2002.
Accepted: 1 November 2002.
| REFERENCES |
|---|
|
|
|---|
in human fallopian tubes. Endocrinology 1992 131:947-957[Abstract]
in human oviduct epithelium and their role in early embryogenesis. Endocrinology 1993 133:199-207[Abstract]
, and epidermal growth factor receptor localization in the baboon (Papio anubis) oviduct during steroid treatment and the menstrual cycle. J Soc Gynecol Invest 1994 1:269-276[Medline]
in estrogen-induced tubal cell growth in vitro. Endocrinology 1995 136:2110-2119[Abstract]
secretion by in vitro fertilized and cultured bovine blastocysts. Hum Reprod 1999 14:2075-2079This article has been cited by other articles:
![]() |
T R. Kumar What have we learned about gonadotropin function from gonadotropin subunit and receptor knockout mice? Reproduction, September 1, 2005; 130(3): 293 - 302. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Fields and M. Shemesh Extragonadal Luteinizing Hormone Receptors in the Reproductive Tract of Domestic Animals Biol Reprod, November 1, 2004; 71(5): 1412 - 1418. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. C. Lin, X. Li, Z. M. Lei, and Ch. V. Rao Human Cervix Contains Functional Luteinizing Hormone/Human Chorionic Gonadotropin Receptors J. Clin. Endocrinol. Metab., July 1, 2003; 88(7): 3409 - 3414. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |